Years ended December 31, | |||||||||
2017 | 2016 | 2015 | |||||||
$ | $ | $ | |||||||
Net loss from continuing operations | (16,796 | ) | (24,959 | ) | (50,228 | ) | |||
Net income from discontinued operations | — | — | 85 | ||||||
Net loss | (16,796 | ) | (24,959 | ) | (50,143 | ) | |||
Basic and diluted weighted average number of shares outstanding | 14,958,704 | 10,348,879 | 2,763,603 | ||||||
Items excluded from the calculation of diluted net loss per share because the exercise price was greater than the average market price of the common shares or due to their anti-dilutive effect | |||||||||
Stock options | 713,918 | 968,397 | 276,661 | ||||||
Share purchase warrants | 3,417,840 | 3,779,245 | 2,842,309 | ||||||